In this Xtalks webinar, Signant Health’s Dr. Alan Kott, Metis Cognition’s Dr. John Harrison, and Karuna Therapeutics‘ Dr. Colin Sauder discuss overcoming CNS trial challenges.

Topics covered include how to:

1. Manage data quality at sites
2. Use artificial intelligence to identify at-risk raters
3. Identify appropriate, reliable participants in schizophrenia and early Alzheimer’s disease trials based on instrument data